Primary hyperaldosteronism resident survival guide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 33: | Line 33: | ||
{{familytree | | |!| | | | | | | | | | | | | |!| }} | {{familytree | | |!| | | | | | | | | | | | | |!| }} | ||
{{familytree | | D01 | | | | | | | | | | | |D02|D01=•Renin-secreting tumors<br>•Diuretic use<br>•Renovascular hypertension<br>•Coarctation of aorta<br>•Malignant phase hypertension|D02=Urinary aldosterone}} | {{familytree | | D01 | | | | | | | | | | | |D02|D01=•Renin-secreting tumors<br>•Diuretic use<br>•Renovascular hypertension<br>•Coarctation of aorta<br>•Malignant phase hypertension|D02=Urinary aldosterone}} | ||
{{familytree | | | | | | | | | | | | | | {{familytree | | | | | | |,|-|-|-|-|-|-|-|-|-|+|-|-|-|-|.|}} | ||
{{familytree | | | | | | | | | | | | | {{familytree | | | | | |E01| | | | | | | |E02| | |E03|E01=Elevated|E02=Normal|E03=Low|}} | ||
{{familytree | | | | | | | | | | | | | | {{familytree | | | | | | |!| | | | | | | | | |!| | | | |!| }} | ||
{{familytree | | | | | | | | | | | | | {{familytree | | | | | |F01| | | | | | | |F02| | |F03|F01=Conn's syndrome (Primary aldosteronism)|F02=Profound K+ depletion|F03=• 17 alpha hydroxylase deficiency<br>• 11 beta hydroxylase deficiency<br>• Liddle's syndrome<br>• Licorice ingestion<br> •Deoxycorticosterone producing tumor|}} | ||
{{familytree | | | | | | | | | | | | | | {{familytree | | | | | | |!| | | | | | | | | | | | | | |!| | | | }} | ||
{{familytree | | | | | | | | | | | | {{familytree | | | | | |G01| | | | | | | | | | | | |G02|G01=Do confirmatory tests:<br> •Fludrocortisone supression test (Positive test= Aldosterone > 6 ng / dl and simultaneous PRA levels < than 1.0 ng / ml / hour)<br>OR<br> •Intravenous saline load testing (Positive test= Aldosterone more than 10 ng / dl)<br>OR<br> •Oral sodium loading test (Positive test= 24-hour urinary aldosterone excretion > 12 μg / day<br>OR<br> •Captopril challenge test (Positive test= PAC / PRA > 30, measured two hours after the administration of 25 mg or 50 mg of captopril)|G02=Add Mineralocrticoid antagonist for 8 weeks}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |,|-|-|^|-|.}} | {{familytree | | | | | | | | | | | | | | | | | | |,|-|-|^|-|.}} | ||
{{familytree | | | | | | | | | | | | | | | | | |H01| | |H02|H01=BP response|H02=No BP response}} | {{familytree | | | | | | | | | | | | | | | | | |H01| | |H02|H01=BP response|H02=No BP response}} | ||
{{familytree | | | | | | | | | | | | | | | | | | |!| | | | |!| }} | {{familytree | | | | | | | | | | | | | | | | | | |!| | | | |!| }} | ||
{{familytree | | | | | | | | | | | | | | | | | |I01 | | |I02|I01=• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency)<br>• Licorice ingestion<br>•Glucocorticoid resistance|I02=Liddle's syndrome)|}} | {{familytree | | | | | | | | | | | | | | | | | |I01 | | |I02|I01=• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency)<br>• Licorice ingestion<br>•Glucocorticoid resistance|I02=Liddle's syndrome)|}} |
Revision as of 18:03, 17 July 2017
Template:Primary hyperladosteronism Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Causes
Common Causes
Common causes of Conn's Syndrome may be divided into:
- Adrenal causes:
- Aldosterone-secreting adrenal adenoma (APA-benign tumor, 50-60%)
- Idiopathic hyperaldosteronism (IHA-Bilateral hyperplasia of the adrenal gland, 40-50%)
- Extra-adrenal causes
- Ectopic secretion of aldosterone (Ovaries and Kidneys)
Less Common Causes
- Familial hyperaldosteronism type I (glucocorticoid-remediable aldosteronism [GRA])
- Familial hyperaldosteronism II (the familial occurrence of APA or bilateral idiopathic hyperplasia or both)
- Familial hyperaldosteronism type III (associated with the germline mutation in the KCNJ5 potassium channel)
- Pure aldosterone-producing adrenocortical carcinomas
- Unilateral adrenal hyperplasia
Diagnosis and Treatment
Preferred screening population: • Blood pressure > 160 / 100 particularly (< 50 years) | |||||||||||||||||||||||||||||||||||||||||||||||||||
Plasma Renin Activity/Aldosterone Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||
Normal or High Renin (Plasma Renin/Aldosterone ratio <10 | Suppressed Renin (Plasma Renin/Aldosterone ratio >20 | ||||||||||||||||||||||||||||||||||||||||||||||||||
•Renin-secreting tumors •Diuretic use •Renovascular hypertension •Coarctation of aorta •Malignant phase hypertension | Urinary aldosterone | ||||||||||||||||||||||||||||||||||||||||||||||||||
Elevated | Normal | Low | |||||||||||||||||||||||||||||||||||||||||||||||||
Conn's syndrome (Primary aldosteronism) | Profound K+ depletion | • 17 alpha hydroxylase deficiency • 11 beta hydroxylase deficiency • Liddle's syndrome • Licorice ingestion •Deoxycorticosterone producing tumor | |||||||||||||||||||||||||||||||||||||||||||||||||
Do confirmatory tests: •Fludrocortisone supression test (Positive test= Aldosterone > 6 ng / dl and simultaneous PRA levels < than 1.0 ng / ml / hour) OR •Intravenous saline load testing (Positive test= Aldosterone more than 10 ng / dl) OR •Oral sodium loading test (Positive test= 24-hour urinary aldosterone excretion > 12 μg / day OR •Captopril challenge test (Positive test= PAC / PRA > 30, measured two hours after the administration of 25 mg or 50 mg of captopril) | Add Mineralocrticoid antagonist for 8 weeks | ||||||||||||||||||||||||||||||||||||||||||||||||||
BP response | No BP response | ||||||||||||||||||||||||||||||||||||||||||||||||||
• Deoxycorticosterone excess( Tumor, 17 alpha hydroxylase and 11 beta hydroxylase deficiency) • Licorice ingestion •Glucocorticoid resistance | Liddle's syndrome) | ||||||||||||||||||||||||||||||||||||||||||||||||||